SSMXY Stock UPDATES Sysmex Corp ADR (SSMXY) 18.9500 09/10/2014
Post# of 273256
Posted On: 09/10/2014 6:47:12 PM
Sysmex Corp ADR (SSMXY) 18.9500 $SSMXY
Global In-Vitro Diagnostics (IVD) Market Forecasts and Opportunities, 2020
M2 - Tue Sep 02, 8:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/sdwv9t/global_in_vitro) has announced the addition of the "Global In Vitro Diagnostics (IVD) Market - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering. The various segments studied in the report include techniques, product, usability, applications, end-user, and geography. Point of care technique of diagnosis is identified as the most popular technique amongst the physicians, clinicians and doctors. It accounted for about 31.0% of the overall IVD market in 2013, and is expected to grow at a CAGR of 3.5% during the forecast period. Major factor contributing for this growth is convenience provided by POC diagnostic devices over conventional diagnostics devices. Instruments, reagents, data management software, and services are studied as the major segments of the global IVD product market of which instruments segment is expected to be the largest revenue-generating segment through 2020. Global IVD market, by usability of diagnostic devices, is classified as disposable and reusable devices. Due to the cost effectiveness and reusability of the devices for multi patient testing, re-usable devices segment holds the lead position; however, disposable devices segment is catching up rapidly at much faster rates. The global market for In Vitro Diagnostics, by application, is segmented into infectious disease, diabetes, cancer, cardiology, autoimmune diseases, nephrology, drug testing, and HIV/AIDS of which diagnosis of infectious disease is the most attractive application market followed by HIV/AIDS. Increase in the number of incidences of such diseases is primary driver for faster adoption of IVD techniques in these applications. Hospitals, laboratories, academics, point of care testing are the major end use segments analyzed in the report and laboratory segment is identified to be the largest end-use segment. Point of care technique provides convenience in diagnosis of disease at home thus it is projected to emerge out as the fastest growing market during the forecast period.The top global market players and their growth strategies are also discussed in this study. Product launch, acquisitions, approvals for various products are some major strategies adopted by the market players to maintain their positions in the competitive environment. The report showcases top players such as: - Abbot Laboratories - Roche Diagnostics - Siemens - Johnson & Johnson - Alere Inc - Arkray Inc - Bayer AG - Becton Dickinson & Company - Biomerieux - Dahaner Corporation - Sysmex Corp KEY MARKET SEGMENTS - Immunoassays - Clinical Chemistry - Point Of Care - Molecular Diagnostics - Hematology - Coagulation - Microbiology - Other clinical techniques MARKET BY PRODUCT TYPE - Instruments - Reagents - Data management systems - Services MARKET BY USABILITY - Disposable - Reusable MARKET BY APPLICATIONS - Infectious Diseases - Diabetes - Cancer/Oncology - Cardiology - Autoimmune Diseases - Nephrology - Drug Testing - HIV/AIDS MARKET BY END USER - Hospitals - Laboratories - Academics - Point of Care Testing - Others For more information visit http://www.researchandmarkets.com/research/sd...l_in_vitro
The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition (2014)
M2 - Wed Aug 27, 3:49AM CDT
Research and Markets (http://www.researchandmarkets.com/research/x2f378/the_worldwide) has announced the addition of the "The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition" report to their offering. This single volume covers the entirety of the clinical testing market and all of its segments, providing customers with a tremendous value. Used by Top IVD Companies For Business Planning. This is the ninth edition of this informative volume based on the market events of 2013 and early 2014. New entrants, new technologies have entered the stage and all important events are cataloged in this report. The idea behind Kalorama's unique report is that the entire market can be captured in one volume. This volume includes market estimates for 2013 base year and forecasts to 2018 for the most important aspects of all of the major segments of clinical lab testing, including: - Core Lab (General Chemistries, Workstations, Analyzers Blood Gases, Urinalysis, Critical Care) - Point of Care (POC), (Professional and Self-Testing, Glucose Testing, Pregnancy Tests, drugs of abuse, HIV, H. pylori, Other, OTC/Self Total, Professional POC, Cardiac Markers, Drugs of Abuse, HbA1c, Pregnancy, Other) - Histology and Cytology (Pap, ISH, IHC, HPV) - Lab-based Infectious Disease Immunoassays, by Test (Hepatitis, HIV, STDs, TORCH, Respiratory, Sepsis, Parasitology, Mycology, Others) - Molecular Assays (Infectious Disease, Blood Screening, Inherited Diseases, Oncology, Pharmacodiagnostics, Tissue Typing, Prenatal) - Hematology - Molecular Test Sales, Infectious Diseases (HAI, HIV, Hepatitis, GC/Chlamydia, Respiratory, Organism ID, Mycobacteria, TB, Others - Lab-based Immunoassay Sales by Analyte Type (Cardiac markers, Tumor markers, Diabetes/HbA1c, Autoimmune, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic drugs, Tox/Drugs of abuse, Vitamin D) - Coagulation (Lab-Based, POC, Genetic Markers) - Microbiology and Virology by Test Type (Immunoassays, ID/AST, Infectious Diseases - DNA; ID/AST: Panels and Reagents, automated; Panels and Reagents, manual; Blood Culture; Chromogenic Media; Rapid Micro; Supplies) - Blood Banking (Grouping, Immunoassay Screens, NAT Screens) At 1200 pages, this is the most comprehensive report on the in vitro diagnostic industry available. No surprise that it has been called the 'Bible of the IVD Industry' by past users of the report. Many of the top IVD companies use this product for business planning, which means that this volume can provide a uniform standard for in vitro diagnostic market numbers. This edition greatly expands coverage of the field and tracks the most important developments. Key Topics Covered: Chapter One: Executive Summary Chapter Two: Introduction Chapter Three: Overview of Global In Vitro Diagnostic Markets Chapter Four: Trends and Innovation Chapter Five: Point-Of-Care Tests Chapter Six: the Core Lab Chapter Seven: Immunoassays Chapter Eight: Molecular Assays Chapter Nine: Hematology Chapter Ten: Coagulation Chapter Eleven: Microbiology and Virology Chapter Twelve: Blood Banking Services Chapter Thirteen: Histology/Cytology Chapter Fourteen: Company Profiles Companies Mentioned - Abbott Diagnostics - Alere Inc. - Arkray - Beckman Coulter, Inc. - Becton, Dickinson and Company (BD) - bioM?rieux Inc. - Bio-Rad Laboratories, Inc. - Danaher Corporation - Hologic, Inc. - Ortho Clinical Diagnostics (OCD) - QIAGEN N.V. - Siemens Healthcare Diagnostics - Sysmex Corporation - Thermo Fisher Scientific Inc. - Cepheid - Eiken Chemical Co., Ltd - ERBA Diagnostics, Inc. - DiaSorin S.p.A - Fujirebio Diagnostics, Inc. - Illumina - LabCorp - Luminex Corporation - Menarini Diagnostics - Myriad Genetics - PerkinElmer, Inc. (PE) - Quest Diagnostics - Quidel Corporation - Randox Laboratories Ltd. - TOSOH Corporation - Wako Pure Chemical Industries And hundreds of other companies... For more information visit http://www.researchandmarkets.com/research/x2..._worldwide
Hematology Instruments and Reagents - 2014 Global Strategic Business Report
M2 - Thu Aug 21, 2:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fz4292/hematology) has announced the addition of the "Hematology Instruments and Reagents - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Hematology Instruments and Reagents in US$ Thousands by the following Product Segments: - Hematology/Coagulation Instruments (Hematology Analyzers, Hematology Flow Cytometers, Coagulation Analyzers, Hemoglobinometers, Slide Stainers, Hematology Centrifuges, & Hematology Vials) - Hematology/Coagulation Reagents (Flow Cytometry Reagents, Coagulation Reagents, Hematology Reagents, Immuno-Hematology Reagents, Control Plasmas, & Hematology Stains). The report profiles 78 companies including many key and niche players such as: - Abbott Diagnostics, Inc. - Beckman Coulter, Inc. - Bio-Rad Laboratories, Inc. - Drucker Diagnostics - Horiba Ltd. - Instrumentation Laboratory, Inc. - Mindray Medical International Limited - Roche Diagnostics - Siemens Healthcare - Sigma-Aldrich Corporation - Stago - Sysmex Corporation - Sysmex America, Inc. - Tcoag Ireland Ltd. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Outlook 2. Industry Overview & Trends 3. Competitive Scenario 4. Key Product Segments 5. Blood The All Pervasive Connective Tissue 6. Hematology The Core Idea 8. Blood Testing Developments A Historic Review 9. Product Introductions/Innovations 10. Recent Industry Activity 11. Focus On Select Players 12. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 78 (including Divisions/Subsidiaries 111) - The United States (40) - Japan (10) - Europe (37) - France (7) - Germany (
- The United Kingdom (5) - Italy (3) - Spain (2) - Rest of Europe (12) - Asia-Pacific (Excluding Japan) (22) - Latin America (1) - Africa (1) For more information visit http://www.researchandmarkets.com/research/fz4292/hematology
Circulating Nucleic Acids (CNAs) Based Non-Invasive Cancer Diagnostics: Global Market Report 2014
M2 - Thu Aug 07, 10:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4mlqf7/circulating) has announced the addition of the "Circulating Nucleic Acids (CNAs) Based Non-Invasive Cancer Diagnostics: Global Market Report" report to their offering. The aim of this report was to review recent advances in use of circulating cell-free miRNA, DNA and mRNA as novel biomarkers which can be used for the detection and diagnosis of cancer, and the impact on making the ongoing research closer to clinical application. The report will also provide a market analysis of the market value, growth rates, market development as well as examining the dynamics and factors influencing the growth and development of this market. This report also looks at the challenges and potential threats facing the industry players, and the factors influencing the market shares of both the major market suppliers and smaller indigenous manufacturers in local markets. The data collection and forecasting methods used in the preparation of this report are broadly divided into three methods. These are primary data and information gathering, secondary data and information gathering and market share analysis and market forecast prediction. Information and data including estimates on market values, growth rates and market share data were gathered from the methods described and were incorporated into proprietary computer forecasting and market share analysis models. The forecast model was used to derive market estimates for future years. It incorporates a rate factor, which helps determine the speed with which the market develops, which is similar to that observed for markets for other medical products and is adjusted to match historic data for the market under analysis. Key Topics Covered: Executive Summary Chapter 1: Introduction to the Circulating Nucleic Acid Market Report Chapter 2: Background to Circulating Nucleic Acids Chapter 3: Cancer: A Statistical Analysis of the Disease Incidence and Prevalence Chapter 4: CNA Based Cancer Diagnostics Market: Revenue Analysis Chapter 5: CNA Based Cancer Diagnostics Market: Market Share Analysis Chapter 6: Company Profiles - Abbott Laboratories (Abbott Molecular) - Affymetrix Inc - Autogenomics - Becton Dickinson and Company (BD) - Beckmann Coulter, Inc (Danaher Corporation) - bioM?rieux - Cancer Genetics, Inc - Cepheid - Dako (Agilent) - Epigenomics - Hologic Gen-Probe - Illumina - Ipsogen (Qiagen) - Luminex - MolecularMD - Myriad Genetics Laboratories - Novartis Diagnostics - Ortho-Clinical Diagnostics (The Carlyle Group) - Oxford Gene Technology (OGT) - Qiagen N.V. - Roche - Siemens - Sysmex Corporation - Thermo Fisher Scientific - Ventana (Roche) - For more information visit http://www.researchandmarkets.com/research/4m...irculating
Hematology Analyzers & Reagents Market - Forecasts to 2019
M2 - Wed Jul 30, 6:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gc4hs3/hematology) has announced the addition of the "Hematology Analyzers & Reagents Market - Forecasts to 2019" report to their offering. The global hematology market is estimated to grow at a lower CAGR in developed countries; however, it is expected to witness high growth in emerging countries such as China, India, and Brazil in the next five years. The growth of the hematology analyzers and reagents market is driven by factors such as increasing adoption of automated hematology instruments by diagnostics laboratories, growing development of the high throughput hematology analyzers, integration of basic flow-cytometry techniques in modern hematology analyzers, developments in high sensitivity Point-of-Care hematology testing, and the introduction of technologically advanced hematology instruments. However, slow adoption of advanced hematology instruments in the emerging economies, hematology product recalls, and the high cost of hematology analyzers are restraining the growth of this market. Rapid growth of hematology market in emerging countries such as India, China and Brazil; introduction of digital imaging systems in hematology laboratories; and growing use of microfluidics technology in hematology analyzer are creating opportunities for the growth of the hematology analyzers and reagents market in these regions. In this report, the global hematology market has been segmented on the basis of type of product (hematology instruments and consumables) & services and by end-users (commercial organizations, stand alone hospitals, research institutes, and clinical testing labs). Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Industry Trends 6 Hematology Products and Services Market 7 Global Hematology Market, By End Users 8 Geographic Analysis 9 Competitive Landscape 10 Company Profiles Companies Mentioned: - Abbott Laboratories - Beckman Coulter - Bio-Rad Laboratories - Boule Diagnostics Ab - Horiba, Ltd. - Mindray Medical International Limited - Nihon Kohden Corporation - Roche Diagnostics - Siemens Healthcare - Sysmex Corporation For more information visit http://www.researchandmarkets.com/research/gc4hs3/hematology
Sysmex Corporation Appoints U.S. Subsidiary CEO John Kershaw to Executive Officer
PR Newswire - Wed Jul 23, 7:44PM CDT
Sysmex America, Inc., the United States subsidiary for Sysmex Corporation, Kobe, Japan, announced that the company's President and Chief Executive Officer, John Kershaw, has been appointed an Executive Officer of Sysmex Corporation. Kershaw's appointment marks the first time an executive from an overseas subsidiary has been appointed. As an Executive Officer, Kershaw will serve in a consultative capacity to the corporation's president and governing board while maintaining his leadership position with Sysmex America.
United States Market for In Vitro Diagnostic Tests Report 2014-2018
M2 - Wed Jul 23, 4:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/x885q3/the_united_states) has announced the addition of the "The United States Market for In Vitro Diagnostic Tests" report to their offering. Advanced flow cytometry and microbiology tests will provide more opportunity for manufacturers than POC tests or clinical chemistry test products sold in the United States. A Relative Opportunity Metric is used to assess the segments of clinical lab testing in the world's largest healthcare market. According to the report, Market growth remains robust for U.S. microbiology diagnostics, a group of IVD segments including traditional microbiology (culturing for ID/AST), rapid tests, molecular infectious disease tests, and immunoassay infectious disease tests. Several market drivers exist for microbiology in the United States: hospital investment in microbiology for health-acquired infection (HAI) testing, investment in automated microbiology systems, rising rates of incidence for several sexually transmitted diseases (STDs), and market penetration by higher-priced molecular infectious disease tests. The report also indicates that advanced IVD tests in this study, including molecular assays for non-infectious disease testing, histology, cytology, and flow cytometry. Molecular assays and histology are projected to be the two-fastest growing IVD market segments in the United States through 2018. Tissue analysis or histology in support of cancer diagnosis and treatment is increasingly reliant on immunohistochemical (IHC) reagents and molecular hybridization (ISH/FISH) techniques and represents a fast rising market in the aging United States. The United States is also ground zero for an influx of advanced molecular assays for blood-based cancer testing, circulating tumor cell (CTC) testing, pharmacodiagnostics, and other sequencing-developed tests. The report, The United States Market for In Vitro Diagnostic Tests, contains further detail on the US IVD market including segment markets and forecasts, corporate profiles, and other information. Key Topics Covered: Chapter One: Executive Summary Chapter Two: Introduction To U.S. Health Care Chapter Three: U.S. Ivd Market Analysis Chapter Four: Top Tier U.S. Ivd Market Players - Abbott Diagnostics - Alere - Beckman Coulter - Becton Dickinson - Danaher Corporation - Hologic - Ortho-Clinical Diagnostics / J&J Diabetes Care - QIAGEN - Roche Diagnostics - Siemens Healthcare Diagnostics - Sysmex Corporation - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/x8...ted_states
In Vitro Diagnostics (POC/Rapid Diagnostics) Global Market - Forecast to 2019
M2 - Mon Jul 21, 9:52AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8h8cv2/in_vitro) has announced the addition of the "In Vitro Diagnostics (POC/Rapid diagnostics) Global market - Forecast to 2019" report to their offering. The Asia-Pacific and RoW regions are expected to register a significant growth rate for the IVD market. North America commands the largest share while Asia Pacific is the fastest revenue growing region. IVD market growth is driven by factors such as increase in incidences of chronic and infectious diseases across all age cohorts, genetic diseases, aging population, rising acceptance of personalized medicine, rise in healthcare awareness in patients and high unmet medical needs in diagnosing diseases. Screening initiatives and high investment in healthcare infrastructures mainly contributes to market growth. Whereas, difficulty in rendering rapid diagnostic results, stringent regulatory policies, reimbursement issues and economic crisis are the major growth restraints. Different geographies is an opportunistic factor which improved IVD market growth. Roche diagnostics (Basel, Switzerland) is expected to be the largest player in the IVD market, followed by Siemens and Abbott. The IVD market is highly consolidated, with the major players holding close to 80% market share. Top ten major players are Roche Diagnostics, Siemens Healthcare(Erlangen, Germany), Abbott(Abbott Park, Illinois), Johnson and Johnson(New Jersey), Beckman Coulter(Massachusetts), Becton Dickinson(U.S.), bioMerieux (France), Bayer Diabetes(Germany), Sysmex (U.S.) and Bio-Rad(California). Key players such as Thermo Fisher Scientific, Inc., QIAGEN N.V., and ARKRAY, Inc. have established new manufacturing facilities and R&D units in China to grow IVD market. The focus of this research report description was on various levels of analysis, industry, market shares, value chain, PESTEL analysis and company profiles which together comprise and augment about competitive landscape, emerging and high growth segments of in vitro diagnostic (molecular diagnostics & point of care testing), emerging technologies. Key Topics Covered: 1. Executive summary 2. Introduction 3. Market Analysis 4. IVD market by Techniques 5. IVD market by Products 6. IVD market by Applications 7. IVD market by End-users 8. IVD market by Usability 9. Regional Market Analysis 10. Company Developments 11. Major Company Profiles - Abbott Laboratories, Inc. - Becton, Dickinson and company - Biomerieux - Bio-Rad Laboratories, Inc - Danaher Corporation - Johnson and Johnson - Roche Diagnostics - Siemens Healthcare - Sysmex Corporation - Thermo Fischer Scientific, Inc For more information visit http://www.researchandmarkets.com/research/8h8cv2/in_vitro
US Hematology Diagnostics Market to 2017
M2 - Wed Jul 02, 8:36AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hb8k3j/us_hematology) has announced the addition of the "US Hematology Diagnostics Market" report to their offering. This research service analyzes and provides forecasts of the US hematology diagnostics market from 2012 to 2017. The market is broadly classified into 2 major segments: analyzers and reagents. The US hematology market was sized using a bottom-up revenue model developed from the actual installed base of hematology analyzers in US laboratories, the data for which were collected through an end-user survey. The number of hematology analyzers installed by manufacturer and model were collected from a sample population of more than 4,000 sites. The sample population included hospitals, reference laboratories, and physician's office laboratories. Key Questions This Study Will Answer: - Is the market growing, how long will it continue to grow, and at what rate? - Are the existing competitors structured correctly to meet customer needs? - How will the structure of the market change over time? Is it ripe for acquisitions? - Which emerging or anticipated companies should be on competitors' radar, and why? - Are the products/services offered today meeting customer needs, or is additional development needed? - Are the vendors in the space ready to go it alone, or do they need partnerships to take their businesses to the next level? Key Topics Covered: 1. Executive Summary 2. Market Overview 3. Competitive Playbook 4. Drivers, Restraints, and TrendsTotal Hematology Diagnostics Market 5. Forecast and TrendsTotal Hematology Diagnostics Market 6. Competitive Environment 7. Product Analysis 8. Hematology Analyzers Segment 9. Hematology Reagents Segment 10. The Last Word 11. Appendix Companies Mentioned - Abbott Diagnostics - Beckman Coulter - Biorad - Horiba ABX - Medica - Mindray - Siemens Diagnostics - Sysmex Corporation For more information visit http://www.researchandmarkets.com/research/hb...hematology
Global In Vitro Diagnostics (IVD) Market (Technique, Product, Usability, Application, End User, and Geography) - Forecast to 2020
M2 - Fri Jun 27, 7:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9xm2bw/global_in_vitro) has announced the addition of the "Global In Vitro Diagnostics (IVD) Market (Technique, Product, Usability, Application, End User, and Geography) - Forecast to 2020" report to their offering. According to this research report titled "In Vitro Diagnostics Market (Techniques, Product Type, Usability, Applications, End-Users, Geography) - Industry Analysis, Trends, Share, Opportunities and Forecast, 2013 - 2020," the global In Vitro Diagnostics market has a potential to reach $74.46 billion by 2020 with North America being the largest regional market. North America is forecast to reach $30.1 billion by 2020 growing at a CAGR of 4.02% during 2014-2020. Asia-Pacific is forecast to be the fastest growing market and is expected to grow at a CAGR of 7.49% during the forecast period (from 2014 to 2020). The IVD market is evolving in the emerging markets due to widespread healthcare awareness and increased spending capabilities of people on healthcare. In addition, high demand of technologically advanced equipment for the early and precise diagnosis of various diseases is further strengthening the market growth in such regions. Key Topics Covered: CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 MARKET OVERVIEW CHAPTER 4 GLOBAL IVD MARKET BY TECHNIQUES CHAPTER 5 GLOBAL IVD MARKET BY PRODUCT TYPE CHAPTER 6 GLOBAL IVD MARKET BY USABILITY CHAPTER 7 GLOBAL IVD MARKET BY APPLICATION CHAPTER 8 GLOBAL IVD MARKET BY END USERS CHAPTER 9 GLOBAL IVD MARKET BY GEOGRAPHY CHAPTER 10 COMPANY PROFILES Companies Mentioned: - Abbot Laboratories - Alere Inc - Arkray Inc - Bayer AG - Becton Dickinson & Company - Biomerieux - Dahaner Corporation - Johnson & Johnson - Roche Diagnostics - Siemens - Sysmex Corp. For more information visit http://www.researchandmarkets.com/research/9x...l_in_vitro
Concise Analysis of the International Cell Surface Markers Market - Forecasts to 2018
M2 - Mon Mar 31, 5:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xkhjg7/cell_surface) has announced the addition of the "Concise Analysis of the International Cell Surface Markers Market - Forecasts to 2018" report to their offering. Cell surface markers are unique to cell types and have vital functional role in immunology. These are generally antigens or molecules present within the plasma membrane of the cell. Such markers serve as the prime component in identification and categorization of cells such as lymphocytes, macrophages, monocytes, tumor cells and other cells majorly related to immunology. Cell surface marker analysis is performed through the use of technologies namely, flow cytometry and hematology analyzers and can be carried out on various samples such as lymph nodes, blood, bone marrow and other tissues. Such analysis may allow simplification of disease diagnosis and identification, sample preparation and drug discovery. Identification of specific types of molecules through cell surface marker analysis helps in efficient disease diagnosis and thereby assists in determination of disease treatment and drugs. Cell surface markers analysis enables the quantification of the scope of new drugs reaching the intended target and are also responsible for achieving the clinical outcomes by altering the proposed pathophysiological mechanisms. Disease diagnosis by detection or use of cell surface markers has been beneficial and critical in developing innovative and reliable indicators with high specificity for the diagnosis and prognosis of different types of diseases, majorly cancer. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Cell Surface Markers Market, by Instruments and Reagents Chapter 5 Global Cell Surface Markers Market, by Applications Chapter 6 Global Cell Surface Markers Market, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles Companies Mentioned: - Abbott Laboratories, Inc - BD Biosciences - Beckman Coulter, Inc - Bio-Rad Laboratories, Inc - F Hoffmann-La Roche Ltd - Grifols SA - Immucor, Inc - Janssen Diagnostics, Inc - Nihon Kohden Corporation - Siemens Healthcare - Sysmex Corporation - Thermo Fischer Scientific, Inc For more information visit http://www.researchandmarkets.com/research/xk...ll_surface
Global Molecular Diagnostics Market 2012-2016: Trends and Collaborations Discussed
M2 - Fri Mar 28, 6:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mchzgs/global_molecular) has announced the addition of the "Global Molecular Diagnostics Market 2012-2016" report to their offering. The analysts forecast the Global Molecular Diagnostics market to grow at a CAGR of 11.42 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing investments in genomics and proteomics research. The Global Molecular Diagnostics market has also been witnessing a growth in the diagnostics segment. However, the compliance with regulatory requirements could pose a challenge to the growth of this market. Key vendors dominating this space include Abbott Laboratories, Becton, Dickinson and Co., QIAGEN N.V., and Roche Holding Ltd. Other vendors mentioned in the report are Affymetrix Inc., Agilent Technologies Inc., Alere Inc., AmniSure International LLC, Anadys Pharmaceuticals Inc., Bayer HealthCare AG, Biocartis SA, bioMerieux SA, Bio-Rad Laboratories Inc., Biotest AG, Carmel Pharma AB, Celera Diagnostics LLC, Cellestis Ltd., Cepheid Inc., Cytometers Inc., Danaher Corp., Diagenode SA, Eli Lilly and Co., Eurogentec S.A., Evotec AG, GE Healthcare Ltd., Genomic Health Inc., Gen-Probe Inc., Illumina Inc., Instrumentation Laboratory Co., IRIS International Inc., Janssen Biotech Inc., KIESTRA Lab Automation BV, Life Technologies Corp., Luminex Corp., Merck and Co. Inc., mtm laboratories AG, Nanosphere Inc., Novartis AG, PerkinElmer Inc., Pharmacyclics Inc., PVT Probenverteiltechnik GmbH, Quest Diagnostics Inc., Quidel Corp., Safety Syringes Inc., SANYO North America Corp., Siemens Healthcare, Sirigen Group Limited, St. Jude Medical Inc., Sysmex Corp., and Thermo Fisher Scientific Inc. Commenting on the report, an analyst from the Healthcare team said: 'The Global Molecular Diagnostics market presents several growth opportunities to vendors. Different vendors in the market are increasingly forming strategic alliances with pharmaceutical companies for the development of companion diagnostics, which helps in producing more effective drugs. For instance, in February 2013, Abbott Laboratories collaborated with Janssen Biotech Inc. and Pharmacyclics Inc. to discover the benefits of Abbott's exclusive FISH technology for use in developing a molecular companion diagnostic test to identify patients with chronic lymphocytic leukemia. For more information visit http://www.researchandmarkets.com/research/mc..._molecular About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
EMD Millipore Announces Clinical Research, Licensing and Joint Development Agreement with Sysmex Corporation
Business Wire - Mon Mar 17, 12:55PM CDT
--Potential to transform hematology research and diagnostics
Concise Analysis of the International In Vitro Diagnostic (IVD) Market - Forecast To 2017
M2 - Tue Mar 11, 6:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nc4zfn/in_vitro) has announced the addition of the "Concise Analysis of the International In Vitro Diagnostic (IVD) Market - Forecast To 2017" report to their offering. The in vitro diagnostic market studied in this report has been segmented by technology, product type, application, end user, and geography. The technology market is further segmented into clinical chemistry, immunochemistry, molecular diagnostics, hematology, coagulation, microbiology, and others, of which immunochemistry accounted for the largest share with 25.8% in 2010. By product type, the IVD market has segments like instruments, reagents, data management software/hardware, and services. Based on applications, the in vitro diagnostic market is segmented as diabetes, infectious diseases, oncology, cardiology, nephrology, auto-immune diseases, AIDS, drug testing, and others. Laboratory testing, hospital testing, academic (AMCs and university) testing, point-of-care testing, patient self-testing, and others comprise the end-user segment of the IVD market. The global in vitro diagnostic market was valued at $49.2 billion in 2012 and is expected to reach $69.1 billion by 2017, at a CAGR of 7% from 2012 to 2017. The IVD market is primarily driven by rising incidences of chronic and infectious diseases in emerging economies, a rapidly aging population, the rise in point-of-care testing, and the rising importance of personalized medicine. However, factors such as stringent regulatory frameworks and a shortage of budget and labor are restraining the growth of the market. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global In Vitro Diagnostic Market, By Technique 5 Global In Vitro Diagnostic Market, By Product Type 6 Global In Vitro Diagnostic Market, By Application 7 Global In Vitro Diagnostic Market, By End-User 8 Geographic Analysis 9 Competitive Landscape 10 Company Profiles Companies Mentioned: - Abbott Laboratories, Inc - Alere, Inc - Arkray, Inc - Bayer AG - Becton, Dickinson And Company - Bio-Rad Laboratories, Inc - Biomerieux - Danaher Corporation - Diagnostica Stago Sas - Diasorin SPA - Hologic, Inc - Horiba, Ltd - Johnson & Johnson - Novartis International Ag - Qiagen NV - Roche Diagnostics Limited - Siemens Healthcare - Sysmex Corporation - Thermo Fisher Scientific, Inc For more information visit http://www.researchandmarkets.com/research/nc4zfn/in_vitro
Global Endocrine Testing Market to 2019: E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests
M2 - Wed Feb 26, 9:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/bk2st3/endocrine_testing) has announced the addition of the "Global Endocrine Testing Market to 2019: E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests" report to their offering. Endocrinology, a branch of medicine deals with the study of structural and functional elements of the endocrine system. This system comprises endocrine glands (thyroid, adrenal, pituitary and others) and secretory organs (pancreas, hypothalamus) that release hormones directly into the blood stream and regulate the body functioning. Endocrine testing market is studied by three major segments namely, by test, by diagnostic technologies and by end users. The test segment is further classified into 11 major hormone tests that includes estradiol (E2), Follicle Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), Luteinizing hormone (LH), Dehydroepiandrosterone sulfate (DHEAS), progesterone, testosterone, Thyroid Stimulating Hormone (TSH), prolactin, cortisol and insulin tests. The market accounts for a wide range of conventional as well as rapid diagnostic kits used for detecting deficiency (hyposecretion) or excess (hypersecretion) secretions of these hormones. The diagnostic technologies segment further describes the technological platforms used in the analysis of the specimen test sample (blood, urine, etc) and is further categorized into five major technologies, tandem mass spectrometry, immunoassay, monoclonal and polyclonal antibody, sensor and clinical chemistry technologies. The end user segment elucidates the endocrine testing market by various end users that includes hospitals, commercial laboratories, ambulatory health care centers, home based tests and physician's offices. The global endocrine testing market is segmented into the following categories: Tests - Estradiol (E2) Test - Follicle Stimulating Hormone (FSH) Test - Human Chorionic Gonadotropin (hCG) Test - Luteinizing Hormone (LH) Test - Dehydroepiandrosterone sulfate (DHEAS) Test - Progesterone Test - Testosterone Test - Thyroid Stimulating Hormone (TSH) Test - Prolactin Test - Cortisol Test - Insulin Test - Others (Gastrin, Thymosin, Secretin, etc.) Diagnostic Technologies - Tandem Mass spectrometry - Immunoassay (Enzyme immunoassays, Radioimmunoassays (RIA)) Technologies - Monoclonal and Polyclonal Antibody Technologies - Sensor (Electrochemical, Biosensors, etc.) Technologies - Clinical Chemistry Technologies - Others (Liquid Chromatography Mass Spectrometry (LC-MS), High performance Liquid Chromatography (HPLC), etc.) Location - Hospitals - Commercial Laboratories - Ambulatory Care Centers - Home Based Tests - Physician Offices Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Endocrine Testing Market, by Test Chapter 5 Endocrine Testing Market, by Diagnostic Technologies Chapter 6 Endocrine Testing Market, by End Users Chapter 7 Endocrine Testing Market, by Geography Chapter 8 Competitive Landscape Chapter 9 Recommendations Chapter 10 Company Profiles Companies Mentioned - Abbott Laboratories - AB SCIEX LLC - Agilent Technologies - Biomedical Diagnostics - bioMerieux - Bio-Rad Laboratories, Inc. - DiaSorin S.p.A - F. Hoffmann-La Roche Ltd. - Laboratory Corporation of America Holdings (LabCorp) - Ortho Clinical Diagnostics - Quest Diagnostics - Siemens Healthcare - Sysmex Corporation - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/bk...ne_testing
Concise Analysis of the International Pico Projectors Market - Forecasts to 2016
M2 - Tue Feb 04, 3:23AM CST
Research and Markets (http://www.researchandmarkets.com/research/vjgw5g/global_pico) has announced the addition of the "Concise Analysis of the International Pico Projectors Market - Forecasts to 2016" report to their offering. Analysts forecast the Global Pico Projectors market to grow at a CAGR of 32.7 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing integration of pico projectors in mobile handsets. The Global Pico Projectors market has also been witnessing increasing adoption of embedded pico projectors. However, limited features in pico projectors could pose a challenge to the growth of this market. "Concise Analysis of the International Pico Projectors Market - Forecasts to 2016", has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, the EMEA, and the APAC regions; it also covers the Global Pico Projectors market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this market space include 3M Co., MicroVision Inc., Optoma Corp., Syndiant Inc., and Texas Instruments Inc. The other vendors mentioned in this report are AAXA Technologies Inc., Acer Inc., Aiptek Inc., bTendo Ltd., Greenlight Optics LLC., Lemoptix SA., Light Blue Optics Ltd., Luminus Device Inc., Maradin Ltd., Mezmeriz Inc., Micron Technology Inc., Opus Microsystems Corp., Samsung Electronics Co. Ltd., Toshiba Corp., and WowWee Group Ltd. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Research Methodology 5. Scope of the Report 6. Market Landscape 7. Geographical Segmentation 8. Vendor Landscape 9. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Key Vendor Analysis 16. Other Reports in this Series Companies Mentioned: - 3M - AAXA Technologies. - Acer - Aiptek - Greenlight Optics - Lemoptix - Light Blue Optics - Luminus Device - Maradin - Mezmeriz - MicroVision - Micron Technology - Optoma - Opus Microsystems - Samsung Electronics - Syndiant - Texas Instruments - Toshiba - WowWee Group - bTendo For more information visit http://www.researchandmarkets.com/research/vj...lobal_pico
Black Alliance for Educational Options Applauds the Center for Education Reform for Insightful Report on Charter Schools
Marketwire - Thu Jan 30, 1:41PM CST
The Black Alliance for Educational Options (BAEO) applauds the Center for Education Reform (CER) for the release of their Survey of America's Charter Schools. The 23-page report provides an in-depth analysis of charter school students, operations, and teachers, and discusses trends over time in the Size and Scope, Demographics, Finance and Operations, and Academic Program of charter schools and insights into why demand for these independent schools has grown.
2013 Report on the International Cell Surface Markers Market - Trends and Forecasts to 2018
M2 - Fri Jan 24, 6:24AM CST
Research and Markets (http://www.researchandmarkets.com/research/ccmnwh/cell_surface) has announced the addition of the "2013 Report on the International Cell Surface Markers Market - Trends and Forecasts to 2018" report to their offering. Cell surface markers serve as the prime component in identification and categorization of cells such as lymphocytes, macrophages, monocytes, tumor cells and other cells majorly related to immunology. Cell surface marker analysis is performed through the use of technologies namely, flow cytometry and hematology analyzers and can be carried out on various samples such as lymph nodes, blood, bone marrow and other tissues. Such analysis may allow simplification of disease diagnosis and identification, sample preparation and drug discovery. Identification of specific types of molecules through cell surface marker analysis helps in efficient disease diagnosis and thereby assists in determination of disease treatment and drugs. Cell surface markers analysis enables the quantification of the scope of new drugs reaching the intended target and are also responsible for achieving the clinical outcomes by altering the proposed pathophysiological mechanisms. Disease diagnosis by detection or use of cell surface markers has been beneficial and critical in developing innovative and reliable indicators with high specificity for the diagnosis and prognosis of different types of diseases, majorly cancer. Companies investing heavily in developing automated systems with improved sample processing and analysis may gain greater benefits in the near future. Introduction of new and cost-effective instruments is further facilitating the growth of new market entrants and is also being achieved via showcasing advantages of the software and technical capabilities of their instruments at various conferences, laboratories, trade shows, web casting and electronic newsletters. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Cell Surface Markers Market, by Instruments and Reagents 5 Global Cell Surface Markers Market, by Applications 6 Global Cell Surface Markers Market, by Geography 7 Recommendations 8 Company Profiles Companies Mentioned: - Abbott Laboratories - BD Biosciences - Beckman Coulter - Bio-Rad Laboratories - F Hoffmann-La Roche - Grifols - Immucor - Janssen Diagnostics - Nihon Kohden Corporation - Siemens Healthcare - Sysmex Corporation - Thermo Fischer Scientific For more information visit http://www.researchandmarkets.com/research/cc...ll_surface
Do You Know How to Read a Report Card?
by Charles Ekyagonza - All Africa Global Media - Fri Jan 17, 1:44AM CST
At the end of every term, learners are given report cards as a way of evaluating their work and behaviour during the term.
Akingbola Challenges Lagos Court's Jurisdiction to Register London Judgment Against Him
by Davidson Iriekpen - All Africa Global Media - Fri Jan 17, 1:37AM CST
A former Managing Director of the defunct Intercontinental Bank Plc., Mr. Erastus Akingbola, has challenged the jurisdiction of a Lagos High Court to register a GBP654 million judgment delivered against him by a London court.
Global In-Vitro Diagnostics (IVD) Market Forecasts and Opportunities, 2020
M2 - Tue Sep 02, 8:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/sdwv9t/global_in_vitro) has announced the addition of the "Global In Vitro Diagnostics (IVD) Market - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering. The various segments studied in the report include techniques, product, usability, applications, end-user, and geography. Point of care technique of diagnosis is identified as the most popular technique amongst the physicians, clinicians and doctors. It accounted for about 31.0% of the overall IVD market in 2013, and is expected to grow at a CAGR of 3.5% during the forecast period. Major factor contributing for this growth is convenience provided by POC diagnostic devices over conventional diagnostics devices. Instruments, reagents, data management software, and services are studied as the major segments of the global IVD product market of which instruments segment is expected to be the largest revenue-generating segment through 2020. Global IVD market, by usability of diagnostic devices, is classified as disposable and reusable devices. Due to the cost effectiveness and reusability of the devices for multi patient testing, re-usable devices segment holds the lead position; however, disposable devices segment is catching up rapidly at much faster rates. The global market for In Vitro Diagnostics, by application, is segmented into infectious disease, diabetes, cancer, cardiology, autoimmune diseases, nephrology, drug testing, and HIV/AIDS of which diagnosis of infectious disease is the most attractive application market followed by HIV/AIDS. Increase in the number of incidences of such diseases is primary driver for faster adoption of IVD techniques in these applications. Hospitals, laboratories, academics, point of care testing are the major end use segments analyzed in the report and laboratory segment is identified to be the largest end-use segment. Point of care technique provides convenience in diagnosis of disease at home thus it is projected to emerge out as the fastest growing market during the forecast period.The top global market players and their growth strategies are also discussed in this study. Product launch, acquisitions, approvals for various products are some major strategies adopted by the market players to maintain their positions in the competitive environment. The report showcases top players such as: - Abbot Laboratories - Roche Diagnostics - Siemens - Johnson & Johnson - Alere Inc - Arkray Inc - Bayer AG - Becton Dickinson & Company - Biomerieux - Dahaner Corporation - Sysmex Corp KEY MARKET SEGMENTS - Immunoassays - Clinical Chemistry - Point Of Care - Molecular Diagnostics - Hematology - Coagulation - Microbiology - Other clinical techniques MARKET BY PRODUCT TYPE - Instruments - Reagents - Data management systems - Services MARKET BY USABILITY - Disposable - Reusable MARKET BY APPLICATIONS - Infectious Diseases - Diabetes - Cancer/Oncology - Cardiology - Autoimmune Diseases - Nephrology - Drug Testing - HIV/AIDS MARKET BY END USER - Hospitals - Laboratories - Academics - Point of Care Testing - Others For more information visit http://www.researchandmarkets.com/research/sd...l_in_vitro
The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition (2014)
M2 - Wed Aug 27, 3:49AM CDT
Research and Markets (http://www.researchandmarkets.com/research/x2f378/the_worldwide) has announced the addition of the "The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition" report to their offering. This single volume covers the entirety of the clinical testing market and all of its segments, providing customers with a tremendous value. Used by Top IVD Companies For Business Planning. This is the ninth edition of this informative volume based on the market events of 2013 and early 2014. New entrants, new technologies have entered the stage and all important events are cataloged in this report. The idea behind Kalorama's unique report is that the entire market can be captured in one volume. This volume includes market estimates for 2013 base year and forecasts to 2018 for the most important aspects of all of the major segments of clinical lab testing, including: - Core Lab (General Chemistries, Workstations, Analyzers Blood Gases, Urinalysis, Critical Care) - Point of Care (POC), (Professional and Self-Testing, Glucose Testing, Pregnancy Tests, drugs of abuse, HIV, H. pylori, Other, OTC/Self Total, Professional POC, Cardiac Markers, Drugs of Abuse, HbA1c, Pregnancy, Other) - Histology and Cytology (Pap, ISH, IHC, HPV) - Lab-based Infectious Disease Immunoassays, by Test (Hepatitis, HIV, STDs, TORCH, Respiratory, Sepsis, Parasitology, Mycology, Others) - Molecular Assays (Infectious Disease, Blood Screening, Inherited Diseases, Oncology, Pharmacodiagnostics, Tissue Typing, Prenatal) - Hematology - Molecular Test Sales, Infectious Diseases (HAI, HIV, Hepatitis, GC/Chlamydia, Respiratory, Organism ID, Mycobacteria, TB, Others - Lab-based Immunoassay Sales by Analyte Type (Cardiac markers, Tumor markers, Diabetes/HbA1c, Autoimmune, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic drugs, Tox/Drugs of abuse, Vitamin D) - Coagulation (Lab-Based, POC, Genetic Markers) - Microbiology and Virology by Test Type (Immunoassays, ID/AST, Infectious Diseases - DNA; ID/AST: Panels and Reagents, automated; Panels and Reagents, manual; Blood Culture; Chromogenic Media; Rapid Micro; Supplies) - Blood Banking (Grouping, Immunoassay Screens, NAT Screens) At 1200 pages, this is the most comprehensive report on the in vitro diagnostic industry available. No surprise that it has been called the 'Bible of the IVD Industry' by past users of the report. Many of the top IVD companies use this product for business planning, which means that this volume can provide a uniform standard for in vitro diagnostic market numbers. This edition greatly expands coverage of the field and tracks the most important developments. Key Topics Covered: Chapter One: Executive Summary Chapter Two: Introduction Chapter Three: Overview of Global In Vitro Diagnostic Markets Chapter Four: Trends and Innovation Chapter Five: Point-Of-Care Tests Chapter Six: the Core Lab Chapter Seven: Immunoassays Chapter Eight: Molecular Assays Chapter Nine: Hematology Chapter Ten: Coagulation Chapter Eleven: Microbiology and Virology Chapter Twelve: Blood Banking Services Chapter Thirteen: Histology/Cytology Chapter Fourteen: Company Profiles Companies Mentioned - Abbott Diagnostics - Alere Inc. - Arkray - Beckman Coulter, Inc. - Becton, Dickinson and Company (BD) - bioM?rieux Inc. - Bio-Rad Laboratories, Inc. - Danaher Corporation - Hologic, Inc. - Ortho Clinical Diagnostics (OCD) - QIAGEN N.V. - Siemens Healthcare Diagnostics - Sysmex Corporation - Thermo Fisher Scientific Inc. - Cepheid - Eiken Chemical Co., Ltd - ERBA Diagnostics, Inc. - DiaSorin S.p.A - Fujirebio Diagnostics, Inc. - Illumina - LabCorp - Luminex Corporation - Menarini Diagnostics - Myriad Genetics - PerkinElmer, Inc. (PE) - Quest Diagnostics - Quidel Corporation - Randox Laboratories Ltd. - TOSOH Corporation - Wako Pure Chemical Industries And hundreds of other companies... For more information visit http://www.researchandmarkets.com/research/x2..._worldwide
Hematology Instruments and Reagents - 2014 Global Strategic Business Report
M2 - Thu Aug 21, 2:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fz4292/hematology) has announced the addition of the "Hematology Instruments and Reagents - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Hematology Instruments and Reagents in US$ Thousands by the following Product Segments: - Hematology/Coagulation Instruments (Hematology Analyzers, Hematology Flow Cytometers, Coagulation Analyzers, Hemoglobinometers, Slide Stainers, Hematology Centrifuges, & Hematology Vials) - Hematology/Coagulation Reagents (Flow Cytometry Reagents, Coagulation Reagents, Hematology Reagents, Immuno-Hematology Reagents, Control Plasmas, & Hematology Stains). The report profiles 78 companies including many key and niche players such as: - Abbott Diagnostics, Inc. - Beckman Coulter, Inc. - Bio-Rad Laboratories, Inc. - Drucker Diagnostics - Horiba Ltd. - Instrumentation Laboratory, Inc. - Mindray Medical International Limited - Roche Diagnostics - Siemens Healthcare - Sigma-Aldrich Corporation - Stago - Sysmex Corporation - Sysmex America, Inc. - Tcoag Ireland Ltd. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Outlook 2. Industry Overview & Trends 3. Competitive Scenario 4. Key Product Segments 5. Blood The All Pervasive Connective Tissue 6. Hematology The Core Idea 8. Blood Testing Developments A Historic Review 9. Product Introductions/Innovations 10. Recent Industry Activity 11. Focus On Select Players 12. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 78 (including Divisions/Subsidiaries 111) - The United States (40) - Japan (10) - Europe (37) - France (7) - Germany (
- The United Kingdom (5) - Italy (3) - Spain (2) - Rest of Europe (12) - Asia-Pacific (Excluding Japan) (22) - Latin America (1) - Africa (1) For more information visit http://www.researchandmarkets.com/research/fz4292/hematology Circulating Nucleic Acids (CNAs) Based Non-Invasive Cancer Diagnostics: Global Market Report 2014
M2 - Thu Aug 07, 10:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4mlqf7/circulating) has announced the addition of the "Circulating Nucleic Acids (CNAs) Based Non-Invasive Cancer Diagnostics: Global Market Report" report to their offering. The aim of this report was to review recent advances in use of circulating cell-free miRNA, DNA and mRNA as novel biomarkers which can be used for the detection and diagnosis of cancer, and the impact on making the ongoing research closer to clinical application. The report will also provide a market analysis of the market value, growth rates, market development as well as examining the dynamics and factors influencing the growth and development of this market. This report also looks at the challenges and potential threats facing the industry players, and the factors influencing the market shares of both the major market suppliers and smaller indigenous manufacturers in local markets. The data collection and forecasting methods used in the preparation of this report are broadly divided into three methods. These are primary data and information gathering, secondary data and information gathering and market share analysis and market forecast prediction. Information and data including estimates on market values, growth rates and market share data were gathered from the methods described and were incorporated into proprietary computer forecasting and market share analysis models. The forecast model was used to derive market estimates for future years. It incorporates a rate factor, which helps determine the speed with which the market develops, which is similar to that observed for markets for other medical products and is adjusted to match historic data for the market under analysis. Key Topics Covered: Executive Summary Chapter 1: Introduction to the Circulating Nucleic Acid Market Report Chapter 2: Background to Circulating Nucleic Acids Chapter 3: Cancer: A Statistical Analysis of the Disease Incidence and Prevalence Chapter 4: CNA Based Cancer Diagnostics Market: Revenue Analysis Chapter 5: CNA Based Cancer Diagnostics Market: Market Share Analysis Chapter 6: Company Profiles - Abbott Laboratories (Abbott Molecular) - Affymetrix Inc - Autogenomics - Becton Dickinson and Company (BD) - Beckmann Coulter, Inc (Danaher Corporation) - bioM?rieux - Cancer Genetics, Inc - Cepheid - Dako (Agilent) - Epigenomics - Hologic Gen-Probe - Illumina - Ipsogen (Qiagen) - Luminex - MolecularMD - Myriad Genetics Laboratories - Novartis Diagnostics - Ortho-Clinical Diagnostics (The Carlyle Group) - Oxford Gene Technology (OGT) - Qiagen N.V. - Roche - Siemens - Sysmex Corporation - Thermo Fisher Scientific - Ventana (Roche) - For more information visit http://www.researchandmarkets.com/research/4m...irculating
Hematology Analyzers & Reagents Market - Forecasts to 2019
M2 - Wed Jul 30, 6:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gc4hs3/hematology) has announced the addition of the "Hematology Analyzers & Reagents Market - Forecasts to 2019" report to their offering. The global hematology market is estimated to grow at a lower CAGR in developed countries; however, it is expected to witness high growth in emerging countries such as China, India, and Brazil in the next five years. The growth of the hematology analyzers and reagents market is driven by factors such as increasing adoption of automated hematology instruments by diagnostics laboratories, growing development of the high throughput hematology analyzers, integration of basic flow-cytometry techniques in modern hematology analyzers, developments in high sensitivity Point-of-Care hematology testing, and the introduction of technologically advanced hematology instruments. However, slow adoption of advanced hematology instruments in the emerging economies, hematology product recalls, and the high cost of hematology analyzers are restraining the growth of this market. Rapid growth of hematology market in emerging countries such as India, China and Brazil; introduction of digital imaging systems in hematology laboratories; and growing use of microfluidics technology in hematology analyzer are creating opportunities for the growth of the hematology analyzers and reagents market in these regions. In this report, the global hematology market has been segmented on the basis of type of product (hematology instruments and consumables) & services and by end-users (commercial organizations, stand alone hospitals, research institutes, and clinical testing labs). Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Industry Trends 6 Hematology Products and Services Market 7 Global Hematology Market, By End Users 8 Geographic Analysis 9 Competitive Landscape 10 Company Profiles Companies Mentioned: - Abbott Laboratories - Beckman Coulter - Bio-Rad Laboratories - Boule Diagnostics Ab - Horiba, Ltd. - Mindray Medical International Limited - Nihon Kohden Corporation - Roche Diagnostics - Siemens Healthcare - Sysmex Corporation For more information visit http://www.researchandmarkets.com/research/gc4hs3/hematology
Sysmex Corporation Appoints U.S. Subsidiary CEO John Kershaw to Executive Officer
PR Newswire - Wed Jul 23, 7:44PM CDT
Sysmex America, Inc., the United States subsidiary for Sysmex Corporation, Kobe, Japan, announced that the company's President and Chief Executive Officer, John Kershaw, has been appointed an Executive Officer of Sysmex Corporation. Kershaw's appointment marks the first time an executive from an overseas subsidiary has been appointed. As an Executive Officer, Kershaw will serve in a consultative capacity to the corporation's president and governing board while maintaining his leadership position with Sysmex America.
United States Market for In Vitro Diagnostic Tests Report 2014-2018
M2 - Wed Jul 23, 4:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/x885q3/the_united_states) has announced the addition of the "The United States Market for In Vitro Diagnostic Tests" report to their offering. Advanced flow cytometry and microbiology tests will provide more opportunity for manufacturers than POC tests or clinical chemistry test products sold in the United States. A Relative Opportunity Metric is used to assess the segments of clinical lab testing in the world's largest healthcare market. According to the report, Market growth remains robust for U.S. microbiology diagnostics, a group of IVD segments including traditional microbiology (culturing for ID/AST), rapid tests, molecular infectious disease tests, and immunoassay infectious disease tests. Several market drivers exist for microbiology in the United States: hospital investment in microbiology for health-acquired infection (HAI) testing, investment in automated microbiology systems, rising rates of incidence for several sexually transmitted diseases (STDs), and market penetration by higher-priced molecular infectious disease tests. The report also indicates that advanced IVD tests in this study, including molecular assays for non-infectious disease testing, histology, cytology, and flow cytometry. Molecular assays and histology are projected to be the two-fastest growing IVD market segments in the United States through 2018. Tissue analysis or histology in support of cancer diagnosis and treatment is increasingly reliant on immunohistochemical (IHC) reagents and molecular hybridization (ISH/FISH) techniques and represents a fast rising market in the aging United States. The United States is also ground zero for an influx of advanced molecular assays for blood-based cancer testing, circulating tumor cell (CTC) testing, pharmacodiagnostics, and other sequencing-developed tests. The report, The United States Market for In Vitro Diagnostic Tests, contains further detail on the US IVD market including segment markets and forecasts, corporate profiles, and other information. Key Topics Covered: Chapter One: Executive Summary Chapter Two: Introduction To U.S. Health Care Chapter Three: U.S. Ivd Market Analysis Chapter Four: Top Tier U.S. Ivd Market Players - Abbott Diagnostics - Alere - Beckman Coulter - Becton Dickinson - Danaher Corporation - Hologic - Ortho-Clinical Diagnostics / J&J Diabetes Care - QIAGEN - Roche Diagnostics - Siemens Healthcare Diagnostics - Sysmex Corporation - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/x8...ted_states
In Vitro Diagnostics (POC/Rapid Diagnostics) Global Market - Forecast to 2019
M2 - Mon Jul 21, 9:52AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8h8cv2/in_vitro) has announced the addition of the "In Vitro Diagnostics (POC/Rapid diagnostics) Global market - Forecast to 2019" report to their offering. The Asia-Pacific and RoW regions are expected to register a significant growth rate for the IVD market. North America commands the largest share while Asia Pacific is the fastest revenue growing region. IVD market growth is driven by factors such as increase in incidences of chronic and infectious diseases across all age cohorts, genetic diseases, aging population, rising acceptance of personalized medicine, rise in healthcare awareness in patients and high unmet medical needs in diagnosing diseases. Screening initiatives and high investment in healthcare infrastructures mainly contributes to market growth. Whereas, difficulty in rendering rapid diagnostic results, stringent regulatory policies, reimbursement issues and economic crisis are the major growth restraints. Different geographies is an opportunistic factor which improved IVD market growth. Roche diagnostics (Basel, Switzerland) is expected to be the largest player in the IVD market, followed by Siemens and Abbott. The IVD market is highly consolidated, with the major players holding close to 80% market share. Top ten major players are Roche Diagnostics, Siemens Healthcare(Erlangen, Germany), Abbott(Abbott Park, Illinois), Johnson and Johnson(New Jersey), Beckman Coulter(Massachusetts), Becton Dickinson(U.S.), bioMerieux (France), Bayer Diabetes(Germany), Sysmex (U.S.) and Bio-Rad(California). Key players such as Thermo Fisher Scientific, Inc., QIAGEN N.V., and ARKRAY, Inc. have established new manufacturing facilities and R&D units in China to grow IVD market. The focus of this research report description was on various levels of analysis, industry, market shares, value chain, PESTEL analysis and company profiles which together comprise and augment about competitive landscape, emerging and high growth segments of in vitro diagnostic (molecular diagnostics & point of care testing), emerging technologies. Key Topics Covered: 1. Executive summary 2. Introduction 3. Market Analysis 4. IVD market by Techniques 5. IVD market by Products 6. IVD market by Applications 7. IVD market by End-users 8. IVD market by Usability 9. Regional Market Analysis 10. Company Developments 11. Major Company Profiles - Abbott Laboratories, Inc. - Becton, Dickinson and company - Biomerieux - Bio-Rad Laboratories, Inc - Danaher Corporation - Johnson and Johnson - Roche Diagnostics - Siemens Healthcare - Sysmex Corporation - Thermo Fischer Scientific, Inc For more information visit http://www.researchandmarkets.com/research/8h8cv2/in_vitro
US Hematology Diagnostics Market to 2017
M2 - Wed Jul 02, 8:36AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hb8k3j/us_hematology) has announced the addition of the "US Hematology Diagnostics Market" report to their offering. This research service analyzes and provides forecasts of the US hematology diagnostics market from 2012 to 2017. The market is broadly classified into 2 major segments: analyzers and reagents. The US hematology market was sized using a bottom-up revenue model developed from the actual installed base of hematology analyzers in US laboratories, the data for which were collected through an end-user survey. The number of hematology analyzers installed by manufacturer and model were collected from a sample population of more than 4,000 sites. The sample population included hospitals, reference laboratories, and physician's office laboratories. Key Questions This Study Will Answer: - Is the market growing, how long will it continue to grow, and at what rate? - Are the existing competitors structured correctly to meet customer needs? - How will the structure of the market change over time? Is it ripe for acquisitions? - Which emerging or anticipated companies should be on competitors' radar, and why? - Are the products/services offered today meeting customer needs, or is additional development needed? - Are the vendors in the space ready to go it alone, or do they need partnerships to take their businesses to the next level? Key Topics Covered: 1. Executive Summary 2. Market Overview 3. Competitive Playbook 4. Drivers, Restraints, and TrendsTotal Hematology Diagnostics Market 5. Forecast and TrendsTotal Hematology Diagnostics Market 6. Competitive Environment 7. Product Analysis 8. Hematology Analyzers Segment 9. Hematology Reagents Segment 10. The Last Word 11. Appendix Companies Mentioned - Abbott Diagnostics - Beckman Coulter - Biorad - Horiba ABX - Medica - Mindray - Siemens Diagnostics - Sysmex Corporation For more information visit http://www.researchandmarkets.com/research/hb...hematology
Global In Vitro Diagnostics (IVD) Market (Technique, Product, Usability, Application, End User, and Geography) - Forecast to 2020
M2 - Fri Jun 27, 7:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9xm2bw/global_in_vitro) has announced the addition of the "Global In Vitro Diagnostics (IVD) Market (Technique, Product, Usability, Application, End User, and Geography) - Forecast to 2020" report to their offering. According to this research report titled "In Vitro Diagnostics Market (Techniques, Product Type, Usability, Applications, End-Users, Geography) - Industry Analysis, Trends, Share, Opportunities and Forecast, 2013 - 2020," the global In Vitro Diagnostics market has a potential to reach $74.46 billion by 2020 with North America being the largest regional market. North America is forecast to reach $30.1 billion by 2020 growing at a CAGR of 4.02% during 2014-2020. Asia-Pacific is forecast to be the fastest growing market and is expected to grow at a CAGR of 7.49% during the forecast period (from 2014 to 2020). The IVD market is evolving in the emerging markets due to widespread healthcare awareness and increased spending capabilities of people on healthcare. In addition, high demand of technologically advanced equipment for the early and precise diagnosis of various diseases is further strengthening the market growth in such regions. Key Topics Covered: CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 MARKET OVERVIEW CHAPTER 4 GLOBAL IVD MARKET BY TECHNIQUES CHAPTER 5 GLOBAL IVD MARKET BY PRODUCT TYPE CHAPTER 6 GLOBAL IVD MARKET BY USABILITY CHAPTER 7 GLOBAL IVD MARKET BY APPLICATION CHAPTER 8 GLOBAL IVD MARKET BY END USERS CHAPTER 9 GLOBAL IVD MARKET BY GEOGRAPHY CHAPTER 10 COMPANY PROFILES Companies Mentioned: - Abbot Laboratories - Alere Inc - Arkray Inc - Bayer AG - Becton Dickinson & Company - Biomerieux - Dahaner Corporation - Johnson & Johnson - Roche Diagnostics - Siemens - Sysmex Corp. For more information visit http://www.researchandmarkets.com/research/9x...l_in_vitro
Concise Analysis of the International Cell Surface Markers Market - Forecasts to 2018
M2 - Mon Mar 31, 5:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xkhjg7/cell_surface) has announced the addition of the "Concise Analysis of the International Cell Surface Markers Market - Forecasts to 2018" report to their offering. Cell surface markers are unique to cell types and have vital functional role in immunology. These are generally antigens or molecules present within the plasma membrane of the cell. Such markers serve as the prime component in identification and categorization of cells such as lymphocytes, macrophages, monocytes, tumor cells and other cells majorly related to immunology. Cell surface marker analysis is performed through the use of technologies namely, flow cytometry and hematology analyzers and can be carried out on various samples such as lymph nodes, blood, bone marrow and other tissues. Such analysis may allow simplification of disease diagnosis and identification, sample preparation and drug discovery. Identification of specific types of molecules through cell surface marker analysis helps in efficient disease diagnosis and thereby assists in determination of disease treatment and drugs. Cell surface markers analysis enables the quantification of the scope of new drugs reaching the intended target and are also responsible for achieving the clinical outcomes by altering the proposed pathophysiological mechanisms. Disease diagnosis by detection or use of cell surface markers has been beneficial and critical in developing innovative and reliable indicators with high specificity for the diagnosis and prognosis of different types of diseases, majorly cancer. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Cell Surface Markers Market, by Instruments and Reagents Chapter 5 Global Cell Surface Markers Market, by Applications Chapter 6 Global Cell Surface Markers Market, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles Companies Mentioned: - Abbott Laboratories, Inc - BD Biosciences - Beckman Coulter, Inc - Bio-Rad Laboratories, Inc - F Hoffmann-La Roche Ltd - Grifols SA - Immucor, Inc - Janssen Diagnostics, Inc - Nihon Kohden Corporation - Siemens Healthcare - Sysmex Corporation - Thermo Fischer Scientific, Inc For more information visit http://www.researchandmarkets.com/research/xk...ll_surface
Global Molecular Diagnostics Market 2012-2016: Trends and Collaborations Discussed
M2 - Fri Mar 28, 6:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mchzgs/global_molecular) has announced the addition of the "Global Molecular Diagnostics Market 2012-2016" report to their offering. The analysts forecast the Global Molecular Diagnostics market to grow at a CAGR of 11.42 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing investments in genomics and proteomics research. The Global Molecular Diagnostics market has also been witnessing a growth in the diagnostics segment. However, the compliance with regulatory requirements could pose a challenge to the growth of this market. Key vendors dominating this space include Abbott Laboratories, Becton, Dickinson and Co., QIAGEN N.V., and Roche Holding Ltd. Other vendors mentioned in the report are Affymetrix Inc., Agilent Technologies Inc., Alere Inc., AmniSure International LLC, Anadys Pharmaceuticals Inc., Bayer HealthCare AG, Biocartis SA, bioMerieux SA, Bio-Rad Laboratories Inc., Biotest AG, Carmel Pharma AB, Celera Diagnostics LLC, Cellestis Ltd., Cepheid Inc., Cytometers Inc., Danaher Corp., Diagenode SA, Eli Lilly and Co., Eurogentec S.A., Evotec AG, GE Healthcare Ltd., Genomic Health Inc., Gen-Probe Inc., Illumina Inc., Instrumentation Laboratory Co., IRIS International Inc., Janssen Biotech Inc., KIESTRA Lab Automation BV, Life Technologies Corp., Luminex Corp., Merck and Co. Inc., mtm laboratories AG, Nanosphere Inc., Novartis AG, PerkinElmer Inc., Pharmacyclics Inc., PVT Probenverteiltechnik GmbH, Quest Diagnostics Inc., Quidel Corp., Safety Syringes Inc., SANYO North America Corp., Siemens Healthcare, Sirigen Group Limited, St. Jude Medical Inc., Sysmex Corp., and Thermo Fisher Scientific Inc. Commenting on the report, an analyst from the Healthcare team said: 'The Global Molecular Diagnostics market presents several growth opportunities to vendors. Different vendors in the market are increasingly forming strategic alliances with pharmaceutical companies for the development of companion diagnostics, which helps in producing more effective drugs. For instance, in February 2013, Abbott Laboratories collaborated with Janssen Biotech Inc. and Pharmacyclics Inc. to discover the benefits of Abbott's exclusive FISH technology for use in developing a molecular companion diagnostic test to identify patients with chronic lymphocytic leukemia. For more information visit http://www.researchandmarkets.com/research/mc..._molecular About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
EMD Millipore Announces Clinical Research, Licensing and Joint Development Agreement with Sysmex Corporation
Business Wire - Mon Mar 17, 12:55PM CDT
--Potential to transform hematology research and diagnostics
Concise Analysis of the International In Vitro Diagnostic (IVD) Market - Forecast To 2017
M2 - Tue Mar 11, 6:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nc4zfn/in_vitro) has announced the addition of the "Concise Analysis of the International In Vitro Diagnostic (IVD) Market - Forecast To 2017" report to their offering. The in vitro diagnostic market studied in this report has been segmented by technology, product type, application, end user, and geography. The technology market is further segmented into clinical chemistry, immunochemistry, molecular diagnostics, hematology, coagulation, microbiology, and others, of which immunochemistry accounted for the largest share with 25.8% in 2010. By product type, the IVD market has segments like instruments, reagents, data management software/hardware, and services. Based on applications, the in vitro diagnostic market is segmented as diabetes, infectious diseases, oncology, cardiology, nephrology, auto-immune diseases, AIDS, drug testing, and others. Laboratory testing, hospital testing, academic (AMCs and university) testing, point-of-care testing, patient self-testing, and others comprise the end-user segment of the IVD market. The global in vitro diagnostic market was valued at $49.2 billion in 2012 and is expected to reach $69.1 billion by 2017, at a CAGR of 7% from 2012 to 2017. The IVD market is primarily driven by rising incidences of chronic and infectious diseases in emerging economies, a rapidly aging population, the rise in point-of-care testing, and the rising importance of personalized medicine. However, factors such as stringent regulatory frameworks and a shortage of budget and labor are restraining the growth of the market. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global In Vitro Diagnostic Market, By Technique 5 Global In Vitro Diagnostic Market, By Product Type 6 Global In Vitro Diagnostic Market, By Application 7 Global In Vitro Diagnostic Market, By End-User 8 Geographic Analysis 9 Competitive Landscape 10 Company Profiles Companies Mentioned: - Abbott Laboratories, Inc - Alere, Inc - Arkray, Inc - Bayer AG - Becton, Dickinson And Company - Bio-Rad Laboratories, Inc - Biomerieux - Danaher Corporation - Diagnostica Stago Sas - Diasorin SPA - Hologic, Inc - Horiba, Ltd - Johnson & Johnson - Novartis International Ag - Qiagen NV - Roche Diagnostics Limited - Siemens Healthcare - Sysmex Corporation - Thermo Fisher Scientific, Inc For more information visit http://www.researchandmarkets.com/research/nc4zfn/in_vitro
Global Endocrine Testing Market to 2019: E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests
M2 - Wed Feb 26, 9:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/bk2st3/endocrine_testing) has announced the addition of the "Global Endocrine Testing Market to 2019: E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests" report to their offering. Endocrinology, a branch of medicine deals with the study of structural and functional elements of the endocrine system. This system comprises endocrine glands (thyroid, adrenal, pituitary and others) and secretory organs (pancreas, hypothalamus) that release hormones directly into the blood stream and regulate the body functioning. Endocrine testing market is studied by three major segments namely, by test, by diagnostic technologies and by end users. The test segment is further classified into 11 major hormone tests that includes estradiol (E2), Follicle Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), Luteinizing hormone (LH), Dehydroepiandrosterone sulfate (DHEAS), progesterone, testosterone, Thyroid Stimulating Hormone (TSH), prolactin, cortisol and insulin tests. The market accounts for a wide range of conventional as well as rapid diagnostic kits used for detecting deficiency (hyposecretion) or excess (hypersecretion) secretions of these hormones. The diagnostic technologies segment further describes the technological platforms used in the analysis of the specimen test sample (blood, urine, etc) and is further categorized into five major technologies, tandem mass spectrometry, immunoassay, monoclonal and polyclonal antibody, sensor and clinical chemistry technologies. The end user segment elucidates the endocrine testing market by various end users that includes hospitals, commercial laboratories, ambulatory health care centers, home based tests and physician's offices. The global endocrine testing market is segmented into the following categories: Tests - Estradiol (E2) Test - Follicle Stimulating Hormone (FSH) Test - Human Chorionic Gonadotropin (hCG) Test - Luteinizing Hormone (LH) Test - Dehydroepiandrosterone sulfate (DHEAS) Test - Progesterone Test - Testosterone Test - Thyroid Stimulating Hormone (TSH) Test - Prolactin Test - Cortisol Test - Insulin Test - Others (Gastrin, Thymosin, Secretin, etc.) Diagnostic Technologies - Tandem Mass spectrometry - Immunoassay (Enzyme immunoassays, Radioimmunoassays (RIA)) Technologies - Monoclonal and Polyclonal Antibody Technologies - Sensor (Electrochemical, Biosensors, etc.) Technologies - Clinical Chemistry Technologies - Others (Liquid Chromatography Mass Spectrometry (LC-MS), High performance Liquid Chromatography (HPLC), etc.) Location - Hospitals - Commercial Laboratories - Ambulatory Care Centers - Home Based Tests - Physician Offices Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Endocrine Testing Market, by Test Chapter 5 Endocrine Testing Market, by Diagnostic Technologies Chapter 6 Endocrine Testing Market, by End Users Chapter 7 Endocrine Testing Market, by Geography Chapter 8 Competitive Landscape Chapter 9 Recommendations Chapter 10 Company Profiles Companies Mentioned - Abbott Laboratories - AB SCIEX LLC - Agilent Technologies - Biomedical Diagnostics - bioMerieux - Bio-Rad Laboratories, Inc. - DiaSorin S.p.A - F. Hoffmann-La Roche Ltd. - Laboratory Corporation of America Holdings (LabCorp) - Ortho Clinical Diagnostics - Quest Diagnostics - Siemens Healthcare - Sysmex Corporation - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/bk...ne_testing
Concise Analysis of the International Pico Projectors Market - Forecasts to 2016
M2 - Tue Feb 04, 3:23AM CST
Research and Markets (http://www.researchandmarkets.com/research/vjgw5g/global_pico) has announced the addition of the "Concise Analysis of the International Pico Projectors Market - Forecasts to 2016" report to their offering. Analysts forecast the Global Pico Projectors market to grow at a CAGR of 32.7 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing integration of pico projectors in mobile handsets. The Global Pico Projectors market has also been witnessing increasing adoption of embedded pico projectors. However, limited features in pico projectors could pose a challenge to the growth of this market. "Concise Analysis of the International Pico Projectors Market - Forecasts to 2016", has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, the EMEA, and the APAC regions; it also covers the Global Pico Projectors market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this market space include 3M Co., MicroVision Inc., Optoma Corp., Syndiant Inc., and Texas Instruments Inc. The other vendors mentioned in this report are AAXA Technologies Inc., Acer Inc., Aiptek Inc., bTendo Ltd., Greenlight Optics LLC., Lemoptix SA., Light Blue Optics Ltd., Luminus Device Inc., Maradin Ltd., Mezmeriz Inc., Micron Technology Inc., Opus Microsystems Corp., Samsung Electronics Co. Ltd., Toshiba Corp., and WowWee Group Ltd. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Research Methodology 5. Scope of the Report 6. Market Landscape 7. Geographical Segmentation 8. Vendor Landscape 9. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Key Vendor Analysis 16. Other Reports in this Series Companies Mentioned: - 3M - AAXA Technologies. - Acer - Aiptek - Greenlight Optics - Lemoptix - Light Blue Optics - Luminus Device - Maradin - Mezmeriz - MicroVision - Micron Technology - Optoma - Opus Microsystems - Samsung Electronics - Syndiant - Texas Instruments - Toshiba - WowWee Group - bTendo For more information visit http://www.researchandmarkets.com/research/vj...lobal_pico
Black Alliance for Educational Options Applauds the Center for Education Reform for Insightful Report on Charter Schools
Marketwire - Thu Jan 30, 1:41PM CST
The Black Alliance for Educational Options (BAEO) applauds the Center for Education Reform (CER) for the release of their Survey of America's Charter Schools. The 23-page report provides an in-depth analysis of charter school students, operations, and teachers, and discusses trends over time in the Size and Scope, Demographics, Finance and Operations, and Academic Program of charter schools and insights into why demand for these independent schools has grown.
2013 Report on the International Cell Surface Markers Market - Trends and Forecasts to 2018
M2 - Fri Jan 24, 6:24AM CST
Research and Markets (http://www.researchandmarkets.com/research/ccmnwh/cell_surface) has announced the addition of the "2013 Report on the International Cell Surface Markers Market - Trends and Forecasts to 2018" report to their offering. Cell surface markers serve as the prime component in identification and categorization of cells such as lymphocytes, macrophages, monocytes, tumor cells and other cells majorly related to immunology. Cell surface marker analysis is performed through the use of technologies namely, flow cytometry and hematology analyzers and can be carried out on various samples such as lymph nodes, blood, bone marrow and other tissues. Such analysis may allow simplification of disease diagnosis and identification, sample preparation and drug discovery. Identification of specific types of molecules through cell surface marker analysis helps in efficient disease diagnosis and thereby assists in determination of disease treatment and drugs. Cell surface markers analysis enables the quantification of the scope of new drugs reaching the intended target and are also responsible for achieving the clinical outcomes by altering the proposed pathophysiological mechanisms. Disease diagnosis by detection or use of cell surface markers has been beneficial and critical in developing innovative and reliable indicators with high specificity for the diagnosis and prognosis of different types of diseases, majorly cancer. Companies investing heavily in developing automated systems with improved sample processing and analysis may gain greater benefits in the near future. Introduction of new and cost-effective instruments is further facilitating the growth of new market entrants and is also being achieved via showcasing advantages of the software and technical capabilities of their instruments at various conferences, laboratories, trade shows, web casting and electronic newsletters. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Cell Surface Markers Market, by Instruments and Reagents 5 Global Cell Surface Markers Market, by Applications 6 Global Cell Surface Markers Market, by Geography 7 Recommendations 8 Company Profiles Companies Mentioned: - Abbott Laboratories - BD Biosciences - Beckman Coulter - Bio-Rad Laboratories - F Hoffmann-La Roche - Grifols - Immucor - Janssen Diagnostics - Nihon Kohden Corporation - Siemens Healthcare - Sysmex Corporation - Thermo Fischer Scientific For more information visit http://www.researchandmarkets.com/research/cc...ll_surface
Do You Know How to Read a Report Card?
by Charles Ekyagonza - All Africa Global Media - Fri Jan 17, 1:44AM CST
At the end of every term, learners are given report cards as a way of evaluating their work and behaviour during the term.
Akingbola Challenges Lagos Court's Jurisdiction to Register London Judgment Against Him
by Davidson Iriekpen - All Africa Global Media - Fri Jan 17, 1:37AM CST
A former Managing Director of the defunct Intercontinental Bank Plc., Mr. Erastus Akingbola, has challenged the jurisdiction of a Lagos High Court to register a GBP654 million judgment delivered against him by a London court.
(0)
(0)Scroll down for more posts ▼